Expanded/Activated Gamma Delta T-cell Infusion
Phase I Study of Ex Vivo Expanded/Activated Gamma Delta T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 38 patients (estimated)
- Sponsors
- University of Kansas Cancer Center, University of Kansas Cancer Center
- Collaborators
- In8bio Inc.
- Tags
- Adoptive Cellular Therapy, T Cell, Post-Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1593
- NCT Identifier
- NCT03533816
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.